CD209 and lymphopenia: Previous studies have shown that ACE2 is barely detected in immune cells, such as T/B cells, which suggests that lymphocytopenia in patients with COVID-19 might be explained by the high expression of CD209 in lymphoid tissue (Zhang et al., 2021).